Log in or Sign up for Free to view tailored content for your specialty!
Lupus News
Genetics vs. environment: Experts still unraveling links in lupus pathogenesis
Experts are still trying to understand the interplay between genetic and environmental factors in lupus disease pathogenesis, according to a presenter at the 2022 Association of Women in Rheumatology Annual Conference.
No adverse childhood outcomes through 17 years after prenatal hydroxychloroquine exposure
Prenatal exposure to hydroxychloroquine in birthing parents with systemic lupus erythematosus results in no significant adverse outcomes in children from breast feeding through 17 years, according to data published in Rheumatology.
Log in or Sign up for Free to view tailored content for your specialty!
Professor honored for endogenous retrovirus expression research in patients with lupus
The Lupus Research Alliance has awarded the 2022 Lupus Insight Prize to Akiko Iwasaki, PhD, for her work connecting endogenous retroviruses and systemic lupus erythematosus.
Systemic inflammation in psoriasis accelerates CVD risk
LOUISVILLE, Ky. — Persistent, chronic inflammation seen in moderate to severe psoriasis is associated with plaque destabilization and rupture that drives MI, and biologic treatment can reduce CV risk, according to a speaker.
Different types of arthritis ‘present very differently’ in synovium, synovial fluid
ORLANDO — Understanding the nature and role of the synovium and synovial fluid is critical to managing various types of arthritis, according to a presenter at the 2022 Rheumatology Nurses Society Annual Conference.
Denial of methotrexate prescriptions post-Roe yields ‘condemnation’
The June 24 Supreme Court decision to overturn Roe vs. Wade continues to reverberate across all of health care, including rheumatology, dermatology and cancer treatment — and in this instance all three at once.
Belimumab becomes first FDA-approved drug for pediatric lupus nephritis
The FDA has approved GlaxoSmithKline’s belimumab for the treatment of children with active lupus nephritis who are also receiving standard therapy, according to a company press release.
HHS: Pharmacies cannot deny prescriptions to patients over abortion concerns
Federal law prohibits pharmacies from refusing to fill prescriptions that may end a pregnancy to patients who are able to become pregnant, according to a newly released HHS guidance.
Vitamin D, fish oil ‘unlikely’ to impact RMD progression
Consuming specific dietary components such as vitamin D or omega-3 is “unlikely to influence the progression” of rheumatic and musculoskeletal diseases, according to a report of systemic reviews published in RMD Open.
Trio of anifrolumab lupus trials show concordant BICLA, SRI(4) responses in most patients
Most patients with systemic lupus erythematosus across a trio of anifrolumab trials demonstrated concordant outcomes on BILAG-based Composite Lupus Assessment and SLE Responder Index responses, according to data.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read